ArticleFrontiers in public health2025
Epidemiological trends of lung cancer attributed to residential radon exposure at global, regional, and national level: a trend analysis study from 1990 to 2021.
Article in Frontiers in public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Impact of Pollution on Cancer: A Systematic Review and Meta-Analysis with Focus on Air Pollution.International journal of environmental research and public health · 2026Pooled it
- Global trends and projections of lung cancer attributable to residential radon exposure, 1990-2050.BMC cancer · 2026Article
- Identifying early-life, environmental, and social stressors as key predictors of U.S. respiratory failure mortality: a machine learning study.Frontiers in public health · 2026Article
- Serum miRNA and Metabolomic Signatures of Residential Radon Exposure in Chiang Mai, Thailand.Toxics · 2025Article
- Lung Cancer Incidence in Counties at Low and High Risk of Radon Exposure: A Population-Based SEER Analysis (1975-2022).medRxiv : the preprint server for health sciences · 2025Article
- Gender disparities in lung cancer and social determinants of environmental risk: a geospatial analysis across Illinois counties.Frontiers in public health · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Lung cancer (LC) remains a leading cause of cancer-related mortality globally, with radon identified as the second major risk factor. This study aimed to analyze the global, regional, and national burden of LC attributed to residential radon exposure from 1990 to 2021. Methods: The Global Burden of Disease (GBD) 2021 database were employed to estimate the disease trends of LC attributed to residential radon exposure across sex, age groups, and socioeconomic development levels via the socio-demographic index (SDI). Trends of the age-standardized rates (ASRs) were evaluated using estimated annual percentage change (EAPC). The relationship of the socio-demographic index (SDI) with ASRs was assessed via Spearman correlation and LOESS regression. Results: In 2021, residential radon caused 82,160 global LC deaths (an increase of 66.87% since 1990), while the ASRs declined globally (ASMR EAPC: -0.26, 95%C: -0.51 to -0.01; ASDR EAPC: -0.65, 95%CI: -0.85 to -0.44). The disease burden of residential radon-induced LC was higher in middle and high latitude nations. With the increase of SDI, ASRs showed a downward trend in most regions, while an upward trend at national level. Across age and sex, the older adult males exhibited higher burden. Conclusion: While global ASRs declined, rising absolute burdens underscore radon's persistent threat, particularly in rapidly urbanizing and high-latitude regions. Targeted radon mitigation, enhanced early detection, and gender-specific interventions are critical.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.